HU167270B - - Google Patents

Info

Publication number
HU167270B
HU167270B HUEI403A HUEI000403A HU167270B HU 167270 B HU167270 B HU 167270B HU EI403 A HUEI403 A HU EI403A HU EI000403 A HUEI000403 A HU EI000403A HU 167270 B HU167270 B HU 167270B
Authority
HU
Hungary
Application number
HUEI403A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22320939&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HU167270(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of HU167270B publication Critical patent/HU167270B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
HUEI403A 1971-01-20 1972-01-19 HU167270B (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10821871A 1971-01-20 1971-01-20

Publications (1)

Publication Number Publication Date
HU167270B true HU167270B (cg-RX-API-DMAC7.html) 1975-09-27

Family

ID=22320939

Family Applications (1)

Application Number Title Priority Date Filing Date
HUEI403A HU167270B (cg-RX-API-DMAC7.html) 1971-01-20 1972-01-19

Country Status (26)

Country Link
US (1) US3781282A (cg-RX-API-DMAC7.html)
JP (1) JPS5544076B1 (cg-RX-API-DMAC7.html)
AR (1) AR194722A1 (cg-RX-API-DMAC7.html)
AT (1) AT314731B (cg-RX-API-DMAC7.html)
BE (1) BE777789A (cg-RX-API-DMAC7.html)
BG (1) BG21611A3 (cg-RX-API-DMAC7.html)
CA (1) CA1010848A (cg-RX-API-DMAC7.html)
CH (1) CH547311A (cg-RX-API-DMAC7.html)
CS (1) CS187354B2 (cg-RX-API-DMAC7.html)
DK (1) DK142950C (cg-RX-API-DMAC7.html)
ES (1) ES398963A1 (cg-RX-API-DMAC7.html)
FI (1) FI60565C (cg-RX-API-DMAC7.html)
FR (1) FR2122987A5 (cg-RX-API-DMAC7.html)
GB (1) GB1336802A (cg-RX-API-DMAC7.html)
HU (1) HU167270B (cg-RX-API-DMAC7.html)
IE (1) IE35964B1 (cg-RX-API-DMAC7.html)
IL (1) IL38565A (cg-RX-API-DMAC7.html)
LU (1) LU64635A1 (cg-RX-API-DMAC7.html)
NL (1) NL172746C (cg-RX-API-DMAC7.html)
NO (1) NO143158C (cg-RX-API-DMAC7.html)
PH (1) PH9590A (cg-RX-API-DMAC7.html)
PL (1) PL83085B1 (cg-RX-API-DMAC7.html)
SE (1) SE380269B (cg-RX-API-DMAC7.html)
SU (1) SU592360A3 (cg-RX-API-DMAC7.html)
YU (1) YU39454B (cg-RX-API-DMAC7.html)
ZA (1) ZA7250B (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52106891A (en) * 1976-03-03 1977-09-07 Shionogi & Co Ltd Removal of carboxyl protecting group
GB1532682A (en) * 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
US4091214A (en) * 1977-02-25 1978-05-23 Eli Lilly And Company De-esterification process for cephalosporins
US4160863A (en) * 1977-04-07 1979-07-10 Bristol-Myers Company Process for the preparation of the crystalline monohydrate of 7-[D-α-aα-(p-hydroxyphenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid
AR223653A1 (es) * 1977-09-27 1981-09-15 Toyama Chemical Co Ltd Procedimiento de preparacion del acido 7-(d(-)-alpha-(4-etil-2,3-dioxo-1-piperazinocarboxamido)-alpha-(4-hidroxifenil)acetamido)-3-(5-(1-metil-1,2,3,4-tetrazolil)tiometil)-delta3-cefem-4-carboxilico y su producto de adicion con n,n-dimetilacetamida
AT363594B (de) * 1978-02-01 1981-08-10 Biochemie Gmbh Verfahren zur herstellung eines neuen formamidkomplexes von 7-beta-(d-2-amino-2-phenylacetamido)-3-methylceph-3-emcarbonsaeure
DE3138409A1 (de) * 1981-09-26 1983-04-21 Robert Bosch Gmbh, 7000 Stuttgart "kraftstoffeinspritzpumpe fuer brennkraftmaschinen"
FR2555989B1 (fr) * 1983-12-06 1987-02-20 Bristol Myers Sa Monohydrate de chlorocephadroxyle
JPS60114271U (ja) * 1984-01-12 1985-08-02 株式会社ボッシュオートモーティブ システム 流体ポンプ
US4775751A (en) * 1985-06-03 1988-10-04 Eli Lilly & Company Process for cephalexin hydrochloride alcoholates
US4977257A (en) * 1988-11-14 1990-12-11 Eli Lilly And Company DMF solvates of a β-lactam antibiotic
US5278157A (en) * 1989-07-10 1994-01-11 Gema, S.A. Stable cephradine hydrate
JPH089630B2 (ja) * 1989-07-10 1996-01-31 ヘマ・ソシエダード・アノニマ 有機化合物の、または関連する改善
IN181697B (cg-RX-API-DMAC7.html) * 1994-04-22 1998-09-05 Ranbaxy Lab Ltd
DE69601051T2 (de) * 1995-05-30 1999-06-10 Ranbaxy Laboratories, Ltd., New Delhi Verfahren zur Spaltung von p-Nitrobenzylester in Cephalosporin
FR2814679B1 (fr) * 2000-09-29 2003-04-11 Cll Pharma Compositions pharmaceutiques dispersibles a base de cephalosporines, leur procede de preparation et leur utilisation
MX2008014711A (es) * 2006-05-19 2008-12-03 Dsm Ip Assets Bv Procedimiento para la cristalizacion de cefadroxilo.

Also Published As

Publication number Publication date
PH9590A (en) 1976-01-19
AR194722A1 (es) 1973-08-14
IE35964B1 (en) 1976-07-07
BG21611A3 (bg) 1976-07-20
DK142950C (da) 1981-10-05
IL38565A0 (en) 1972-03-28
DE2202227A1 (de) 1972-11-30
BE777789A (fr) 1972-07-06
DE2202227B2 (de) 1976-05-26
FI60565C (fi) 1982-02-10
AT314731B (de) 1974-04-25
JPS5544076B1 (cg-RX-API-DMAC7.html) 1980-11-10
CA1010848A (en) 1977-05-24
ES398963A1 (es) 1974-10-16
NL172746C (nl) 1983-10-17
GB1336802A (en) 1973-11-14
FR2122987A5 (cg-RX-API-DMAC7.html) 1972-09-01
YU11872A (en) 1982-02-28
LU64635A1 (cg-RX-API-DMAC7.html) 1972-08-23
PL83085B1 (cg-RX-API-DMAC7.html) 1975-12-31
SU592360A3 (ru) 1978-02-05
CH547311A (fr) 1974-03-29
NL172746B (nl) 1983-05-16
FI60565B (fi) 1981-10-30
SE380269B (sv) 1975-11-03
CS187354B2 (en) 1979-01-31
IE35964L (en) 1972-07-20
US3781282A (en) 1973-12-25
NL7200712A (cg-RX-API-DMAC7.html) 1972-07-24
YU39454B (en) 1984-12-31
NO143158B (no) 1980-09-15
ZA7250B (en) 1973-08-29
IL38565A (en) 1975-02-10
NO143158C (no) 1980-12-29
DK142950B (da) 1981-03-02

Similar Documents

Publication Publication Date Title
FR2122987A5 (cg-RX-API-DMAC7.html)
ATA136472A (cg-RX-API-DMAC7.html)
AU2691671A (cg-RX-API-DMAC7.html)
AU2726271A (cg-RX-API-DMAC7.html)
AU2742671A (cg-RX-API-DMAC7.html)
AU2894671A (cg-RX-API-DMAC7.html)
AU2941471A (cg-RX-API-DMAC7.html)
AU2952271A (cg-RX-API-DMAC7.html)
AU3005371A (cg-RX-API-DMAC7.html)
AU442402B2 (cg-RX-API-DMAC7.html)
AU2415871A (cg-RX-API-DMAC7.html)
AU2837671A (cg-RX-API-DMAC7.html)
AU2684171A (cg-RX-API-DMAC7.html)
AU2880771A (cg-RX-API-DMAC7.html)
AU2706571A (cg-RX-API-DMAC7.html)
AU2875571A (cg-RX-API-DMAC7.html)
AU2724971A (cg-RX-API-DMAC7.html)
AU3038671A (cg-RX-API-DMAC7.html)
AU2399971A (cg-RX-API-DMAC7.html)
AU1109576A (cg-RX-API-DMAC7.html)
AU3025871A (cg-RX-API-DMAC7.html)
AU2740271A (cg-RX-API-DMAC7.html)
AU2963771A (cg-RX-API-DMAC7.html)
AU2755871A (cg-RX-API-DMAC7.html)
AR202997Q (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
HU90 Patent valid on 900628